Dr Chris Schilling
PhD, MSc, BEng (Hons)/BCom(Hons)
Dr Chris Schilling is an academic and consultant health economist who works across the OPUS CRE to provide health economics, economic evaluation and economic modelling support. His research priorities include improving the cost-effectiveness of surgery, understanding the economics of trials, and reducing low-value care in the treatment of osteoarthritis. Chris is involved in teaching both ‘Health Economics’ and ‘Economic Evaluation’, and supervision of PhD and Master students. In consultancy (KPMG), Chris leads a team of health economists providing economic evaluation and modelling to a range of government and industry clients. His work has influenced key public policy debates around obesity, mental health, low-value care and e-cigarettes.
Schilling, C., Keating, C., Barker, A., Wilson, S.F. and Petrie, D., 2018. Predictors of inpatient rehabilitation after total knee replacement: an analysis of private hospital claims data. Medical Journal of Australia, 209(5), pp.222-227.
Schilling, C., Petrie, D., Dowsey, M.M., Choong, P.F. and Clarke, P., 2017. The Impact of Regression to the Mean on Economic Evaluation in Quasi‐Experimental Pre–Post Studies: The Example of Total Knee Replacement Using Data from the Osteoarthritis Initiative. Health economics, 26(12), pp.e35-e51.
Schilling, C.G., Dowsey, M.M., Petrie, D.J., Clarke, P.M. and Choong, P.F., 2017. Predicting the long-term gains in health-related quality of life after total knee arthroplasty. The Journal of arthroplasty, 32(2), pp.395-401.
Excellence in Doctoral Research, University of Melbourne, 2018
Postgraduate scholarship, National Health and Medical Research Council (NHMRC) 2015-2017
Best Paper, Australian Health Economics Society Doctoral Workshop 2015
Best Sessional Presentation, University of Melbourne School of Population and Global Health PhD Workshop 2015
OTHER KEY ROLES
KPMG Economics: Associate Director